Porvair to produce materials for filtration and diffusion
BioVyon polymer materials are aimed at pharmaceutical and biotech companies
BioVyon materials are primarily made from polyethylene or polypropylene sintered porous plastic, made by proprietary cGMP processes with low extractable and particle shedding levels. Available in pore sizes from 5 to 100 micron (mean flow pore) the materials are available in sheet, roll, cut shapes or moulded and, depending on the particular specification, have regulatory approvals that meet FDA, WDA and USP requirements.
Porvair Filtration Group has opened a Class 100000 (ISO Class 8) cleanroom at its Wrexham, UK site to produce and package regulatory controlled materials and assembled products in a clean environment.
An ISO 9001-2000 quality assurance programme, cGMP practices and cleanroom environment to ensure products meet the stringent requirements of the life science industries, underpins the manufacture of these specialist high performance products.
You may also like
Trending Articles
You may also like
Manufacturing
Schütz to build automated IBC production facility at BASF's Ludwigshafen headquarters
Packaging specialist Schütz has signed an agreement with BASF to construct a highly automated intermediate bulk container manufacturing and storage facility directly adjacent to the chemical giant's main plant in Ludwigshafen, enabling round-the-clock just-in-time delivery
Manufacturing
SGD Pharma partners with Prince Sterilisation Services for pharmaceutical glass packaging
The pair have already launched the My Sterinity Nasal platform, a new, versatile sterile vial range within SGD Pharma's My Sterinity RTU platform, using the company's U-Save Type I vials, which are designed to support the growing segment of high-value nasal drug delivery
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Packaging
RFID and smart labels: a new frontier in pharma packaging
Smart RFID and NFC labels are moving beyond simple identification to enable real-time traceability, automated inventory management and enhanced patient safety, positioning advanced labelling as a strategic tool in pharmaceutical manufacturing and hospital supply chains